Table 2.
Association of MICAL1 expression with clinicopathologic characteristics (logistic regression)
| Characteristics | Total(N) | Odds Ratio(OR) | p value |
|---|---|---|---|
| Gender (Male vs. Female) | 530 | 0.820 (0.573–1.171) | 0.275 |
| Age (> 60 vs. <=60) | 530 | 0.785 (0.558–1.104) | 0.165 |
| T stage (T2-T4 vs. T1) | 530 | 1.986 (1.408–2.812) | *** |
| N stage (N1 vs. N0) | 255 | 1.546 (0.556–4.669) | 0.413 |
| M stage (M1 vs. M0) | 498 | 1.391 (0.857–2.270) | 0.183 |
| Pathologic stage (Stage III- IV vs. Stage I- II) | 527 | 1.826 (1.283–2.609) | *** |
| Histologic grade (G3-G4 vs. G1-G2) | 522 | 1.338 (0.948–1.891) | 0.098 |
| Primary therapy outcome (CR vs. PD/SD/PR) | 138 | 0.700 (0.251–1.895) | 0.483 |
***: p < 0.001